• No results found

Next generation antibiotics: progress toward the synthesis of an enzyme-activated nitric oxide-releasing fluorescent prodrug

N/A
N/A
Protected

Academic year: 2021

Share "Next generation antibiotics: progress toward the synthesis of an enzyme-activated nitric oxide-releasing fluorescent prodrug"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Next Generation Antibiotics: Progress Toward the Synthesis of an

Enzyme-Activated Nitric Oxide-Releasing Fluorescent Prodrug

Hailey A. J. Hibbard, Melissa M. Reynolds

Department of Chemistry, Colorado State University

Abstract

Bacterial resistance to antibiotics is spreading at an alarming rate, and without the

development of new antibiotics, common infections will become deadly. The goal of this project is to synthesize an enzyme-activated antibiotic prodrug that detects and kills

bacteria. The antibiotic will incorporate nitric oxide, a known antibacterial agent, and a fluorescent compound to visualize bacterial presence. A synthesis procedure was

developed to synthesize a fluorescent compound attached to a small signaling compound. A nitric oxide donor will be added in the future. In the presence of bacteria, the antibiotic prodrug is designed to simultaneously fluoresce and release nitric oxide.

Esterase

Anti-leukemia activity

Cytochrome P450 enzymes Protects against liver toxicity

AcOM-PYRRO/NO V-PYRRO/NO

N-diazeniumdiolates

NO donor group

Project Idea

Create a small molecule that detects and kills bacteria

• Enzymatically-activated NO prodrug senses bacteria, releases NO to kill bacteria

Model compound Non-fluorescent compound

Bacterial studies performed by Bella Neufeld of the Reynolds group

Fluorescent color of synthesized compounds changes as expected in the presence of Pseudomonas aeruginosa

Add diazeniumdiolate group

Special thanks to Dr. Melissa Reynolds for her help and guidance. Thanks to Bella Neufeld of the Reynolds group for performing the bacterial studies, and Lei Yang of the Schoenfisch group for performing the NO addition reactions.

Introduction

Multiple mechanisms of action against bacteria

Nitric Oxide (NO)

Inactive drug metabolism Active drug Prodrugs

Cellier, et. al. PLOS ONE, 2016, 11.

amino acid NO sensor enzyme NO spontaneous amino acid NO sensor sensor Fluorescent compound

Protease Sensor Synthesis

Fluorescent Sensor Synthesis

Model Compound Synthesis

Non-Fluorescent Compound Synthesis

NO addition reactions run by Lei Yang of the Schoenfisch group at UNC Chapel Hill

A B C

λmax A: 263, 413 nm λmax B: 258 nm λmax C: 250 nm

0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 230 260 290 320 350 380 410 440 470 500 Abs orbanc e (a.u .) Wavelength (nm)

Compounds A-C in 0.01 M NaOH

A B C 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 0 5 10 15 20 25 30 Abs orbanc e (a.u .) Time (hours)

Water Decomposition Experiment

B C

Bacterial Studies

Positive control Boc-protected fluorescent sensor Boc-deprotected fluorescent sensor No new antibiotics Deadly infections

UV-Vis Product Analysis

Conclusions

References and Acknowledgements

Reynolds group

Future Directions

• Synthesized fluorescent sensor, attached amino acid, fluoresces in presence of P.

aeruginosa

• Attached amino acid to model compound

• Attached amino acid to non-fluorescent compound

• Analyzed samples reacted with NO, diazeniumdiolate group on non-fluorescent compound

Measure NO release

Measure antimicrobial activity against bacteria

Antibiotic Resistance Threats in the United States, 2013. CDC.

1. Billiar, T. R. Annals of Surgery. 1995, 221, 4, 339-349.

2. Schairer, D. O.; Chouake, J. S.; Nosanchuk, J. D.; Friedman, A. J. Virulence

2012, 3 (3), 271.

3. Privett, B. J.; Broadnax, A. D.; Bauman, S. J.; Riccio, D. A.; Schoenfisch, M. H.

Nitric Oxide 2012, 26 (3), 169.

4. Cellier, et. al. PLOS ONE, 2016, 11.

5. Keefer, L. K. Annu. Rev. Pharmacol. Toxicol. 2003, 43 (1), 585. 6. Hrabie, J. A.; Keefer, L. K. Chem. Rev. 2002, 102 (4), 1135.

References

Related documents

We determined the cellular mRNA expression of all intrarenal nitric oxide (NO)-producing NO synthase (NOS) isoforms, endothelial NOS (eNOS) and neuronal NOS (nNOS) and inducible

Key words: nitric oxide, leukotrienes, prostaglandins, histamine, ovalbumin, contractions, distal lung, rat, human, guinea pig, precision-cut lung slices, mast cell... LIST

By exposing healthy subjects to hypergravity and microgravity (weightlessness), it was concluded that hypergravity-induced impaired matching of blood and gas in the lungs

In mice with DSS-induced colitis (paper III and IV), histological examination revealed mucosal lesions, oedema, crypt damage, and inflammatory infiltrates. Methotrexate,

Figure 7: Nitric oxide concentration measured as parts per billion (ppb) in air incubated in a catheter balloon in the vagina of 18 patients with diagnosed vaginitis and in the

In this thesis, the involvement of NO in inflammatory reactions as well as its regulatory role on motility in the GI tract was elucidated by studying the differential

Over the past decade, investigators studying NO biology and metabolism have demonstrated that the nitrite anion serves as a unique player in modulating tissue NO

the product would be “ppm-hours” as used by others (69). The design of paper IV did not allow us to determine the effects on surfactant if lower levels of iNO or prolonged periods